Personal tools
  • mobilize, resist, transform
You are here: Home english publications link issue 93 e93biotechtrouble
 

voices icon

 

e93biotechtrouble

  issue 93 link
april/june 2000   

 

BIOTECH IN TROUBLE

The agricultural biotechnology industry's situation is desperate and deteriorating. To be sure, genetically engineered (GE) food is still selling briskly on grocery shelves in the US, but probably only because GE products are not labelled, so consumers have no idea what they're buying.

to label or not to label
At present, an estimated two-thirds of all products for sale in US grocery stores contain genetically engineered crops, and none of them are labelled as such. However, polls show that US consumers overwhelmingly want GE foods labelled. A TIME magazine poll in January 1999 showed that 81 percent of respondents thought GE foods should be labelled. A month earlier, a poll of US consumers by the Swiss drug firm Novartis had found that more than 90 percent of the public wants labelling.

For five years, the GE food industry has been saying that biotech foods can't be labelled because it would require segregating GE from non-GE crops -- a practical impossibility, they claimed. However, in December 1999, Monsanto announced that it had developed a new strain of rapeseed (a crop used to make canola cooking oil) that might raise the levels of vitamin A in humans. How could consumers identify (and pay a premium price for) such a product if it weren't labelled? Obviously labelling will become possible -- indeed, essential -- when it serves the interests of biotech corporations.

Many food suppliers seem to have figured out for themselves how to segregate GE from non-GE crops. According to the New York Times, Kellogg's, Kraft Foods, McDonald's, Nestle USA, and Quaker Oats all sell gene-altered foods in the US but not overseas. Gerber and HJ Heinz announced some time ago that they have managed to exclude genetically modified crops from their baby foods.

For its part, the US government has steadfastly maintained that the labelling of GE foods is not necessary -- and might even be misleading -- because traditional crops and GE crops are "substantially equivalent." For example, the government has maintained that Monsanto's New Leaf potato -- which has been genetically engineered to incorporate a pesticide into every cell in order to kill potato beetles -- is substantially equivalent to normal potatoes, even though the New Leaf potato is, itself, required to be registered as a pesticide with the US Environmental Protection Agency.

Now the government's position has become untenable. In February this year, the government agreed to the international Biosafety Protocol, a treaty with 130 other nations, in which all signatories agree that genetically modified crops are significantly different from traditional crops. Thus the US government has now formally acknowledged that GE crops are not "substantially equivalent" to traditional crops.

trouble brewing
Meanwhile, a groundswell of consumer protest reached a crescendo last year in England and the rest of Europe, then spread to Japan and the US where it has severely eroded investor confidence in the industry. Major US firms that had invested heavily in the technology are now being forced to pull back. Monsanto, Novartis and AstraZeneca all announced in early January that they are turning away from -- or abandoning entirely -- the concept of "life sciences", a business model that combines pharmaceuticals and agricultural products. The New York Times reported in January that Monsanto will eventually shed its entire agricultural operation. In late February, DuPont announced that it was returning to its traditional industrial chemical business to generate profits.

Investors are not the only ones turning away from GE foods. The Wall Street Journal announced in late April that fast-food chains such as McDonald's Corp. are quietly telling their french-fry suppliers to stop using Monsanto's pesticidal New Leaf potato. "Virtually all the [fast food] chains have told us they prefer to take non-genetically modified potatoes," said a spokesperson for the J.M. Simplot Company of Boise, Idaho, a major potato supplier. Earlier this year, Frito Lay also told its corn farmers to abandon GM varieties of corn for use in the company's various snack foods.

According to the New York Times, US farmers have sustained a serious financial blow because they adopted genetically engineered crops so rapidly. In 1996, the US sold $3 billion worth of corn and soybeans to Europe. Last year, those exports had shrunk to $1 billion -- a $2 billion loss. The seed sellers like Monsanto and DuPont got their money from the farmers, so it is the farmers who have taken the hit, and not the biotech firms. The Wall Street Journal reported on 28 April that "American farmers, worried by the controversy, are retreating from the genetically modified seed they raced to embrace in the 1990s ... Government and industry surveys show that US farmers plan to grow millions fewer acres of genetically modified corn, soybeans and cotton than they did last year."

The biotech firms dispute this assessment. They say demand for GM crops has never been better. Less than a year ago Robert Shapiro, the Chief Executive Officer of Monsanto, said bravely, "This is the single most successful introduction of technology in the history of agriculture, including the plow." This year a spokesperson for Monsanto said, "We're seeing a very stable market. There's no major step backward; it's now a matter of how much we'll grow." But Gary Goldberg, president of the American Corn Growers Association, told the New York Times recently that he believes that GM corn plantings will be down about 16 percent this year, compared to last. He indicated that biotech firms are resorting to deception to maintain sales: "The [agricultural biotech] companies are deceiving farmers into thinking their neighbours are planting GM," he told the New York Times.

new developments
In coming days, GE food is likely to receive more attention from the public. Last month, the National Academy of Sciences issued a report confirming what critics have been saying about GE crops: they have the potential to produce unexpected allergens and toxicants in food, and the potential to create far-reaching environmental effects (see article this issue). The Academy said there was no firm evidence that GE foods on the market now have harmful effects on humans or the environment, but at the same time indicated that testing procedures to date have been woefully deficient. Indeed, the present regulatory system is voluntary, not mandatory, so it is possible that the government may not even know about all of the GE foods being sold in the US today.

The Academy pointed out that roughly 40 GE food products have so far been approved for sale in the US, but approvals have also been given for an additional 6,700 field trials of GM plants. And a 3 May New York Times story about super-fast-growing GE salmon noted that "a menagerie of other genetically modified animals is in the works.... Borrowing genes from various creatures and implanting them in others, scientists are creating fast-growing trout and catfish, oysters that can withstand viruses, and an 'enviropig', whose feces are less harmful to the environment because they contain less phosphorus."

The Clinton/Gore administration announced recently that it will "strengthen" the regulatory system for GE foods, but said the new regulations will definitely not require genetically engineered products to carry a label. Thus the government's latest regulatory initiative makes one thing crystal clear: what the Clinton/Gore administration and the biotech companies fear most is an informed public.

It will take years before anyone knows what these new regulations entail, or how effective they will prove to be. By that time, there may have been hundreds of GM plants and animals introduced into the environment with little or no regulatory oversight. The public is legitimately concerned about this. In response to these concerns, biotech corporations have begun to spend tens of millions of dollars on a public relations campaign because "the public has the right to know more about the benefits of biotechnology."

Excerpted from Rachel’s Environment and Health Weekly, #695, 4 May 2000.

Subscriptions to Rachel's are available from listserv@rachel.org with the words SUBSCRIBE RACHEL-WEEKLY YOUR NAME in the message

top table of contents


Document Actions